EP. 2: How is Molecular Testing Used to Select Upfront Therapy in Patients with EGFR Mutations?October 11th 2016
EP. 5: How Will the Availability of Liquid Biopsy Change the Paradigm of Genetic Testing in the Setting of Metastatic Lung Cancer?October 11th 2016
EP. 6: How Has the Availability of Osimertinib Changed the Treatment Paradigm for Repeat Molecular Testing at Progression?October 11th 2016
